Scynexis: Update Following Restructuring Of GSK Deal: Scynexis ended 2023 with $98M, but is still trading at a $54M market cap. Cash runway is beyond 2 years ...
seekingalpha.com/article/4681721-scynexis-update-following-restructuring-of-gsk-deal
Paid articlePaid
Pharmac inks deal with GlaxoSmithKline for new cancer, HIV and COPD drugs: About 30,000 New Zealanders with ovarian cancer, lung disease, HIV and other ...
rnz.co.nz/news/national/514103/pharmac-inks-deal-with-glaxosmithkline-for-new-cancer-hiv-and-copd-drugs
French pharmaceutical giant Sanofi has reached a tentative agreement to settle thousands of US lawsuits which link their heartburn pill Zantac to cancer www.reuters.com/legal/sanofi-settle-4000-zantac-cancer-lawsuits-us-state-courts-2024-04-03/
Unlocking the Secret to Radiant Health with Sensodyne: The Vital Role of Dental Care During Ramadan - News | Khaleej Times
khaleejtimes.com/lifestyle/health/unlocking-the-secret-to-radiant-health-with-sensodyne-the-vital-role-of-dental-care-during-ramadan
In Bridgerton and Flonase Collaboration, Both Love and Allergies Are in Bloom: Shonaland proposed the collaboration ahead of Bridgerton's Season 3 premiere.
adweek.com/creativity/bridgerton-flonase-collaboration-shondaland/
Why you should get your rash checked to know if it’s shingles : If not diagnosed and treated right away, shingles can lead to serious complications
rappler.com/brandrap/why-get-rash-checked-shingles/
Pfizer wants the first FDA approval ever for an RSV vaccine for young adults: There is currently no approved RSV vaccine for adults 18-59 years old
qz.com/pfizer-rsv-younger-adults-18-59-fda-approval-1851397604
Pfizer RSV Vaccine Could Get Wider Use. New Study Suggests a Benefit For All Adults.
barrons.com/articles/pfizer-fda-rsv-vaccine-shot-gsk-moderna-4b1d50cc
Paid articlePaid
Valuations hurdle likely to keep GSK Pharma stock under pressure: Even as the top pharmaceutical peers delivered a double digit growth in the December quarter ...
business-standard.com/companies/news/valuations-hurdle-likely-to-keep-gsk-pharma-stock-under-pressure-124040500916_1.html
Paid articlePaid
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.: Pfizer’s patent expirations are great for humanity but terrible for investors ...
barrons.com/articles/big-pharma-stocks-investors-mistakes-90e3c575
Paid articlePaid
Did you know that if you’ve had chickenpox before, you are more at risk of developing shingles? #BrandRap GSK
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.: Pfizer’s patent expirations are great for humanity but terrible for investors ...
barrons.com/articles/big-pharma-stocks-investors-mistakes-90e3c575
Paid articlePaid
The Nigerian Conundrum for Companies: Stay or Go?: Unilever, Walmart and GSK take different approaches to one of the world’s biggest markets ...
wsj.com/world/africa/the-nigerian-conundrum-for-companies-stay-or-go-1c6418f1
Is the Shingles Vaccine Worthwhile? : If you were vaccinated against shingles pre-2020, you received a product called Zostavax. The new vaccine on the scene ...
health.clevelandclinic.org/which-vaccine-can-best-protect-me-against-shingles
Pfizer offloads $3.9 bln stake in Sensodyne-maker Haleon: Haleon said on Tuesday top shareholder Pfizer offloaded a roughly $3.9 billion stake in the consumer ...
reuters.com/markets/deals/pfizer-offloads-39-bln-stake-sensodyne-maker-haleon-2024-03-19/
GSK to cap out-of-pocket inhaler costs in US: British pharmaceutical giant GSK said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and ...
reuters.com/business/healthcare-pharmaceuticals/gsk-cap-out-of-pocket-inhaler-costs-us-2024-03-20/
AstraZeneca will cap inhaler costs at $35 per month: The cost-reduction strategy follows a similar move from Boehringer Ingelheim, a rival in the medical device ...
washingtonpost.com/business/2024/03/18/astrazeneca-inhaler-price-cap/
Quick Glance: AstraZeneca caps out-of-pocket costs for inhalers
- AstraZeneca announced it will cap out-of-pocket costs for inhaled respiratory products in the US at $35 per month, following a similar move by rival Boehringer Ingelheim.
- This decision comes amidst increasing political scrutiny of high drug prices in the US, particularly for inhalers used to treat asthma and chronic obstructive pulmonary disease.
- The out-of-pocket cost cap will be effective from June 1 for AstraZeneca's entire respiratory product portfolio, including popular inhalers like Airsupra, Bevespi Aerosphere, and Breztri Aerosphere.
- AstraZeneca CEO Pascal Soriot emphasized the need for comprehensive healthcare reform to ensure patients can afford essential medications.
GSK CEO Emma Walmsley's total pay rises 51% to nearly 13 mln pounds in 2023: GSK CEO Emma Walmsley's total remuneration rose 51% to 12.7 million pounds ($16 ...
reut.rs/3SR9yxO
New Gonorrhea Pill Is as Good as It Gets Amid Drug Resistant Strains, Says GSK: A new antibiotic pill for gonorrhea was as good as current treatments in a late ...
bloomberg.com/news/articles/2024-02-26/new-gonorrhea-pill-is-as-good-as-it-gets-amid-drug-resistant-strains-says-gsk
GSK settles another lawsuit on heartburn drug Zantac in California: GSK agreed to confidentially settle another lawsuit in California that had alleged its ...
reuters.com/legal/gsk-confidentially-settles-another-california-zantac-lawsuit-2024-02-29/
Over the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a record-high close on Friday ... Show more cnb.cx/3P0RYq6
GSK Says HIV Shot Is Better than Daily Pills for Some Patients: GSK Plc’s long-acting HIV drug worked better than daily pills for some patients ...
bloomberg.com/news/articles/2024-02-21/gsk-says-hiv-shot-is-better-than-daily-pills-for-some-patients
Sensodyne-maker Haleon jumps on share buyback, falling debt
reuters.com/business/retail-consumer/consumer-health-giant-haleon-sees-higher-revenue-2024-2024-02-29/
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
cnbc.com/2024/02/26/granolas-stocks-power-europe-to-record-highs-drawing-magnificent-7-comparisons.html
Covid-19 anniversary: How have GSK and Astrazeneca fared since?: GSK and Astrazeneca, both played a role in the battle against Covid-19, but how have they fared ...
cityam.com/covid-19-anniversary-how-have-gsk-and-astrazeneca-fared-since/
GSK completes acquisition of Aiolos Bio for up to $1.4 bln: GSK said on Thursday it had completed the acquisition of Aiolos Bio, a clinical-stage ...
reuters.com/business/healthcare-pharmaceuticals/gsk-completes-acquisition-aiolos-bio-up-14-bln-2024-02-15/
UK Risks Critical Medicine Shortage as EU Lures Drugmakers, Sandoz Says: Britain risks running out of critical medicines because it’s failing to stay competitive ...
bloomberg.com/news/articles/2024-03-22/uk-risks-critical-medicine-shortage-as-eu-lures-drugmakers
Paid articlePaid
Massive TB vaccine trial starts in SA – could deliver first new jab in over a century
dailymaverick.co.za/article/2024-03-19-massive-tb-vaccine-trial-starts-in-sa-could-deliver-first-new-jab-in-over-a-century/
GSK settles another Zantac lawsuit in California: GSK said on Thursday it had agreed to settle another lawsuit in California that alleged its discontinued ...
reut.rs/4bldhfj
Quick Glance: South Africa's Goalkeeper Leads Team to Africa Cup of Nations Semi-Finals
- South Africa's Ronwen Williams saves four penalties, securing a spot in the Africa Cup of Nations semi-finals.
- Mothobi Mvala scores decisive penalty in 2-1 shootout win after 0-0 draw, sending South Africa to their first semi-final since 2000.
- Williams makes brilliant saves, carrying South Africa to victory after dominating the early exchanges and surviving several scares.
- South Africa to face Nigeria in semi-final match on Wednesday.
Return or reputation? Néstle and GSK cases show what really drives ESG action: Investors filed a resolution against Nestlé on healthy foods but have not taken ...
businesspost.ie/analysis-opinion/return-or-reputation-nestle-and-gsk-cases-show-what-really-drives-esg-action/
Paid articlePaid
This New AI Chip Makes Nvidia’s H100 Look Puny in Comparison
barrons.com/articles/cerebras-chip-ai-b1f62550
Paid articlePaid
Major investors unconcerned about GSK’s lack of payout for mother and baby home survivors
businesspost.ie/news/major-investors-unconcerned-about-gsks-lack-of-payout-for-mother-and-baby-home-survivors/
Paid articlePaid
Could new vaccines end malaria in Africa?: A decades-long pursuit to disarm mosquitoes has produced new vaccines. But will they be enough?
aljazeera.com/news/2024/2/12/could-new-vaccines-end-malaria-in-africa
GSK plc (GSK) TD Cowen 44th Annual Health Care Conference (Transcript): GSK plc (NYSE:NYSE:GSK) TD Cowen 44th Annual Health Care Conference March 4 ...
seekingalpha.com/article/4677395-gsk-plc-gsk-td-cowen-44th-annual-health-care-conference-transcript
Urinary tract infection & gonorrhea: new antibiotic tested: There may be a new oral option in the future for treating uncomplicated urinary tract infections and ...
ptaheute.de/aktuelles/2024/03/11/harnwegsinfekt-amp-gonorrhoe-neues-antibiotikum-getestet
Myths and misconceptions about shingles: Myths and misconceptions about shingles
news.abs-cbn.com/lifestyle/2024/3/8/myths-and-misconceptions-about-shingles-1611
Care & Repair Cymru given funding after winning GSK award: Welsh charity, Care & Repair Cymru (CRC), has won an award for its work helping vulnerable older ...
southwalesargus.co.uk/news/24167895.care-repair-cymru-given-funding-winning-gsk-award/
GSK settles another Zantac lawsuit in California: GSK (GSK.L) said on Thursday it had agreed to settle another lawsuit in California that alleged its ...
reuters.com/business/healthcare-pharmaceuticals/gsk-confidentially-settles-another-zantac-lawsuit-california-2024-02-01/
Doctors and parents are scrambling after asthma inhaler switch takes popular medication off the market
cnn.com/2024/02/13/health/asthma-medication-flovent/
Paid articlePaid
GlaxoSmithKline Egypt concluded 2023 with significant sales leap, exceeding two billion pounds, a 23% increase over the previous year ...
english.ahram.org.eg/NewsContent/3/14/518848/Business/Markets--Companies/GlaxoSmithKline-Egypt-concluded--with-significant-.aspx
Amma Birth Companions scoops GSK IMPACT Award and £40,000 funding: A charity which helps vulnerable woman, refugees and asylum seekers on their journey to giving ...
heraldscotland.com/news/24160397.amma-birth-companions-scoops-gsk-impact-award-40-000-funding/
23andMe is low on cash and its stock is worth pennies. The CEO wants another chance
cnn.com/2024/02/02/investing/23andme-stock-anne-wojcicki/
Paid articlePaid
Parents scramble as common children's asthma med disappears: Senator Elizabeth Warren on Friday accused the drug's manufacturer, GlaxoSmithKline ...
bostonglobe.com/2024/03/03/metro/asthma-flovent-glaxo-smith-kline-children-warren/
The impressive rally of the S&P 500 is largely driven by seven US technology giants such as Apple and Amazon. But a similar phenomenon can also be found in ... Show more ow.ly/JX2f50QJJvY
RSV vaccination: US authorities report possible small increase in Guillain-Barré syndromes
aerzteblatt.de/nachrichten/149715/RSV-Impfung-US-Behoerden-melden-moeglichen-geringen-Anstieg-von-Guillain-Barre-Syndromen
How Often Do You Need an RSV Shot? A CDC Call Has High Stakes for GSK, Moderna.: The agency’s vaccine advisory committee could offer clues about an eventual call ...
barrons.com/articles/gsk-moderna-stock-rsv-vaccines-26e5f86b
Paid articlePaid
Sanofi (SAN FP): Deal Could Boost Jumbo LBO Comeback: The Sanofi consumer health-care business would be a great deal for private equity — so long as industrial ...
bloomberg.com/opinion/articles/2024-02-26/sanofi-san-fp-deal-could-boost-jumbo-lbo-comeback
Paid articlePaid
GSK sees strong growth as respiratory, cancer portfolio to pay off: GSK (GSK.L) beat market estimates for fourth-quarter results on Wednesday ...
reuters.com/business/healthcare-pharmaceuticals/drugmaker-gsks-fourth-quarter-results-beat-market-estimate-2024-01-31/
A dispute over a common asthma drug leaves patients caught in the middle: The most common asthma inhaler for children was discontinued at the start of this year ...
thehill.com/policy/healthcare/4472283-a-dispute-over-a-common-asthma-drug-leaves-patients-caught-in-the-middle/
Sensodyne launches alcohol-free mouthwash for sensitive teeth: Sensodyne Complete Protection+ Mouthwash is formulated to complement daily brushing ...
financialexpress.com/business/brandwagon-sensodyne-launches-alcohol-free-mouthwash-for-sensitive-teeth-3395304/
Nigeria is struggling to contain its naira crisis, and global businesses are fleeing Africa's most populous country trib.al/IeF8Elt
GSK plc: An Undervalued Vaccine Behemoth That Is Resuming Growth; Buy: GSK plc’s franchise only faces minor patent cliffs over the next 5-10 years ...
seekingalpha.com/article/4670438-gsk-undervalued-vaccine-behemoth-resuming-growth-buy
Paid articlePaid
Newsquest Cumbria thank sponsors ahead of Pride of Cumbria Awards 2024: NEWSQUEST Cumbria has thanked sponsors ahead of the 2024 Pride of Cumbria awards which ...
nwemail.co.uk/news/24112619.newsquest-cumbria-thank-sponsors-ahead-pride-cumbria-awards-2024/
GSK India arm's Q3 profit falls on government price cap: GlaxoSmithKline Pharmaceuticals , the Indian unit of the UK's GSK , reported a 3% fall in third-quarter ...
reut.rs/3OFEJL8
AstraZeneca Stock Slips on Soft Earnings Report as Cancer Drug Sales Disappoint: The drugmaker AstraZeneca reported underwhelming earnings for its fourth quarter ...
barrons.com/articles/astrazeneca-earnings-stock-price-6ee446ba
Paid articlePaid
Newsquest's Pride of Cumbria Awards launched for 2024: CUMBRIA is a county renowned for its community spirit and pride.
nwemail.co.uk/news/24092807.newsquests-pride-cumbria-awards-launched-2024/
Multinationals Exit Kenya: German firm Bayer is cutting back in Kenya, handing off major tasks. This follows UK's GlaxoSmithKline and foreshadows
riotimesonline.com/multinationals-exit-kenya/
GSK Reports Earnings Wednesday. Investors Are Watching the RSV Vaccine Showdown.: GSK reports earnings Wednesday in a week week for pharmaceutical companies’ ...
barrons.com/articles/gsk-earnings-stock-price-98e16db2
Paid articlePaid
Teva, GSK Report Bullish Earnings. Here's Where Novartis Fell Short.: Teva stock neared a profit-taking zone Wednesday, while GSK stock bounded briefly out ...
investors.com/news/technology/teva-stock-teva-earnings-q4-2023/
New malaria vaccine rolled out in Cameroon may lower mortality risk in children by 13%
medicalnewstoday.com/articles/new-cameroon-malaria-vaccine-lower-all-cause-mortality-risk-in-children
Compensation scheme for medical trial victims at mother and baby homes to open, but GSK won’t contribute
irishtimes.com/health/2024/01/28/compensation-scheme-for-medical-trial-victims-at-mother-and-baby-homes-to-open-but-gsk-wont-contribute/
Is This the Cure for Restless Legs? : George Lundberg speculates that a change in diet rather than another drug could relieve restless leg symptoms.
medscape.com/viewarticle/999627
Haleon sells ChapStick lip balm brand for $430mn : Consumer health company spun out of GSK announces deal as it strives to simplify its portfolio
ft.com/content/3a27551b-dbae-414f-8281-ea00147b3591
The malaria vaccine that just rolled out has a surprise benefit for kids: A new malaria vaccine came to Cameroon this week and will be introduced in 20 ...
npr.org/sections/goatsandsoda/2024/01/24/1226387171/the-malaria-vaccine-that-just-rolled-out-has-a-surprise-benefit-for-kids
Quick Glance: Cameroon's Landmark Initiative: Malaria Vaccination for Kids
- Cameroon is launching the world's first malaria vaccination program for children, aiming to vaccinate approximately 250,000 kids this year and next.
- The campaign's commencement is deemed a pivotal moment in the long-standing battle against the mosquito-borne disease on the continent.
- Gavi is collaborating with 20 other African nations to assist in vaccine procurement, with hopes of immunizing over 6 million children in these countries by 2025.
- Neither of the malaria vaccines halts transmission, thus emphasizing the continued significance of tools such as bed nets and insecticidal spraying.
How a British scientist helped make a malaria vaccine a reality: Decades of work led to two new vaccines, R21 and RTS,S — and it’s the first time a jab has been ...
thetimes.co.uk/article/malaria-vaccine-r21-british-scientists-reality-qh2jv7mgq
Paid articlePaid
GSK boosts respiratory portfolio with $1.4 bln Aiolos Bio deal: GSK (GSK.L) on Tuesday said it would acquire asthma drug maker Aiolos Bio in a deal worth up to ...
reuters.com/markets/deals/gsk-acquire-aiolos-bio-14-bln-deal-2024-01-09/
Quick Glance: VW utilizing ChatGPT for driver conversations by mid-year
- Volkswagen integrating ChatGPT to enable driver conversations by mid-year.
- First vehicles with ChatGPT available in North America and Europe from early second quarter.
- AI system capable of recognizing and responding to various demands, such as temperature adjustments and displaying nearby restaurants.
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics